Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Gliosarcoma 10Glioblastoma 9Carcinoma, Non-Small-Cell Lung 5Salivary Gland Neoplasms 3Astrocytoma 3Adenocarcinoma of Lung 3Squamous Cell Carcinoma of Head and Neck 2Pinealoma 2Pancreatic Neoplasms 2Medulloblastoma 2Head and Neck Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sarcoma 1Rectal Neoplasms 1Radiation Injuries 1Pancreatic Intraductal Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Ototoxicity 1Osteosarcoma 1Oligodendroglioma 1Neuroma, Acoustic 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Lung Neoplasms 1

Interventions

pegaspargase 2merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2blinatumomab 2azathiopurine 2auricularum 2Vincristine 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2Methotrexate 2Mercaptopurine 2Dexamethasone 2Cytarabine 2Calcium Dobesilate 2Asparaginase 2prednylidene 1hydrocortisone hemisuccinate 1deltacortene 1calaspargase pegol 1asparaginase erwinia chrysanthemi recombinant 1Thioguanine 1Spinal Puncture 1Specimen Handling 1Radiotherapy, Conformal 1Radiotherapy 1Radiation 1Prednisone 1Prednisolone 1Nivolumab 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Down Syndrome × Radiotherapy, Conformal × Clear all
NCT04546399 2025-09-10

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

National Cancer Institute (NCI)

Phase 2 Recruiting
461 enrolled
Lymphoid

Burkitt Lymphoma, Down Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡